News

A Philippine lawmaker slammed the U.S. for its travel advisory for the Asian country, with the politician arguing that the warning is "unfair" coming from "our number one ally." ...
Over 250 Brazilian developers have signed an open letter to Gamescom LATAM, accusing the event of mismanagement. As spotted by Game Developer , the complaints from Game Devs Unidos (GDU ) include high ...
The US Department of Health and Human Services said Wednesday that Secretary Robert F. Kennedy Jr. sent a letter urging health care providers and medical boards to update treatment protocols for ...
The US Department of Health and Human Services said Wednesday that Secretary Robert F. Kennedy Jr. sent a letter urging health care providers and medical boards to update treatment protocols for ...
We do not deserve this unfair treatment from our number one ally," he continued. On May 8, the U.S. State Department issued a "Level 2: Exercise Increased Caution" travel advisory for the Philippines.
We do not deserve this unfair treatment from our No 1 ally.” The May 8 advisory, issued by the US State Department, mostly placed the Philippines in the “Level 2” category, meaning ...
Finance Minister K.N. Balagopal has accused the Union government of bias in permitting Maharashtra to accept foreign aid for its Chief Minister’s Distress Relief Fund (CMDRF).
The letter also said that HHS is committed to protecting whistleblowers and may soon create new policies and oversight actions to “hold providers that harm children accountable.” ...
PSTA drivers push for higher pay, claim unfair treatment. BY Angie Angers Pinellas County. UPDATED 3:23 PM ET Feb. 09, 2022 PUBLISHED 7:54 AM ET Feb. 09, 2022 PUBLISHED 7:54 AM EST Feb. 09, 2022.
“They [the Thomson-Moores] wouldn’t have done a deal with me without my good name. I came here for protection and not to be slaughtered.” Mr Magnier said he is not a “legal person” and ...
Chief executive makes remarks after Secretary of State Marco Rubio says Trump administration will ‘aggressively revoke visas for Chinese students’.
The FDA has slapped Savara with a refuse to file (RTF) letter after the biotech in March applied for approval of molgramostim in the rare disease autoimmune pulmonary alveolar proteinosis (aPAP).